baber/WOPTO huggingface dataset:
Patent DE-60004191-D1 (DE)
Inventor: DIDRIKSEN JOHANNES
IPC: A61K47/14
Filed: 2000-04-05
Granted: 2003-09-04
Abstract: The invention refers to an aqueous pharmaceutical composition for parenteral use, said composition comprising i) as active substance a vitamin D or a vitamin D analogue having a solubility in water of </=0.1 % w/v at room temperature, and which is susceptible to gradation in an aqueous acidic environment, ii) a non-ionic solubilizer capable of solubilizing said active substance, the solubilizer being a low histamine-releaser and containing a fatty acid ester of polyethylene glycol optionally in admixture with a polyethylene glycol and having no negative effect on the stability of the active substance in the final composition determined as described herein, and iii) an aqueous vehicle. Moreover, this invention refers to the use of a polyethylene glycol ester as a non-ionic solubilizer.
Patent DE-60012193-D1 (DE)
Inventor: PINZON CHRISTIAN
IPC: H02J3/24
Filed: 2000-12-01
Granted: 2004-08-19
Abstract: In a method and system for assessing the stability of an electric power transmission network, where at least one pair of measurements comprising a first and a second measurement point (P1,P2), each measurement point comprising a voltage and a current phasor, is processed and where a Thévenin impedance (Zt) and a present stability margin (dS(k)) value are computed, a validity indicator (v) is computed which depends on whether there is a difference between the first and second measurement points and whether there is a difference between corresponding estimated first and second load impedances (Za). From all validity indicators (v) associated with all of the at least one pair of measurements a quality indicator (q) is computed that is associated with the Thévenin impedance value (Zt) and with the present stability margin (dS(k)). The invention allows to continuously compute and output a present stability margin (dS(k)) value and to provide a measure (q) of its quality. <IMAGE>
Patent DE-60012560-D1 (DE)
Inventor: STENERSEN EIVIND
IPC: B01D27/08
Filed: 2000-09-20
Granted: 2004-09-02
Abstract: Liquid filter constructions include a baffle plate secured to a can, by way of laser welding. A filter element is operably oriented within the interior of the can. The filter element includes a first end cap (124) and a media pack (54) secured to the first end cap. In some embodiments, the first end cap radially abuts an outer, annular surface of a tubular member (74) of the baffle plate to form a radially directed seal between the first end cap and the tubular member. Liquid filter constructions of this type have a burst strength beween 500-800 psi (about 3.4-5.5 MPa), along a longitudinal section of the can wall. Constructions of this type eliminate a roll or lock seam, an inner gasket, an inner compressive spring, and a gasket retainer. Systems for using liquid filters are described herein. Methods of constructing and using these types of filter arrangements are also described.
Patent DE-60016936-D1 (DE)
Inventor: MCELHINNEY JOHN JOSEPH
IPC: C09D7/41
Filed: 2000-08-23
Granted: 2005-01-27
Abstract: A fluidizing agent which is a diamine and/or diquaternary ammonium salt of a coloured acid of the phthalocyanine or disazo series of dyestuffs wherein the diamine or diquaternary ammonium cation is of formula (1) wherein R is optionally substituted C6-30-alkyl or optionally substituted C6-30-alkenyl; R<1 >is hydrogen, optionally substituted C1-30-alkyl or C2-30-alkenyl, optionally substituted cycloalkyl, optionally substituted aryl or optionally substituted aralkyl; R<2>, R<3 >and R<5 >are each, individually, optionally substituted C1-6-alkyl, optionally substituted cycloalkyl, optionally substituted aryl or optionally substituted aralkyl; R<4 >is hydrogen, optionally substituted C1-6-alkyl, optionally substituted cycloalkyl, optionally substituted aryl or optionally substituted aralkyl; X is C1-12-alkylene or C2-14-alkenylene; or R<1 >and R<3 >together with the two nitrogen atoms to which they are attached and X form a ring; and/or R<4 >and R<5 >together with the nitrogen atom to which they are attached form a ring. Preferably, R is C14-18-alkyl, X is propylene and R<1 >to R<5 >is methyl.
Patent DE-60027172-D1 (DE)
Inventor: LOCHTEFELD J
IPC: A63B69/00
Filed: 2000-08-02
Granted: 2006-05-18
Abstract: A mobile and compact simulated-wave water ride attraction is provided having one or more sluice slide-over covers for ensuring the safety of riders in the absence of an extended transition surface or using a shortened transition surface. Advantageously, the ride attraction comprises a plurality of transportable modules and other associated components that can be shipped between sites using trucks, trains or other transportation means. The slide-over sluice cover advantageously enables riders to safely slide over the sluice gate and/or injection nozzle without risk of injury or interference with ride operation. The sluice cover comprises a contoured flexible pad which covers and extends over the top surface of the sluice gate. A flexible tongue is provided which is urged downward squeezing against the flow and sealing the nozzle area off from possible injurious contact from a rider. The shape of the tongue also provides a short transition surface over the top of which a rider can slide without injury. A padded fixed decking is provided and in conjunction with the sluice cover it allows the rider to perform a variety of new and exciting skimming/surfing tricks and maneuvers.
Patent DE-60028740-D1 (DE)
Inventor: BOLD GUIDO
IPC: C07D401/12
Filed: 2000-03-28
Granted: 2006-07-27
Abstract: The invention relates to the treatment of leukemias with an inhibitor of the activity of VEGF receptor tyrosine kinase of the formula I, the substituents being defined in the specification; as well as to new phthalazine derivatives; processes for the preparation thereof; the application thereof in a process for the treatment of the human or animal body; the use thereof for the treatment of a disease, especially a disease caused by ocular neovascularization, such as age-related macula degeneration or diabetic retinopathy, or other diseases that respond to the inhibition of tyrosine kinases, such as a proliferative disease; a method for the treatment of such disease in mammals; and the use of such a compound for the manufacture of a pharmaceutical preparation for the treatment especially of a disease as mentioned above.
Patent DE-60030719-D1 (DE)
Inventor: JENSEN JACOB
IPC: E06B7/28
Filed: 2000-06-26
Granted: 2006-10-26
Abstract: The present invention relates to an openable screen element such as an insert unit to be inserted into an opening of a wall, particularly a door or a window, comprising at least one screen element side-hinged to the frame structure, said screen element being pivotally mounted over a hinge axis in the frame structure for opening and closing in a direction away from the opening, where the screen element comprises two mutually angled planar sectional elements preferably rectangular in shape, positioned in different planes with an intersection line essentially parallel with the hinge axis. Apart from being communication surfaces containing information of the activities in a room with one or more doors according to the invention mounted into the walls, the screen element, such as a door surface of a screen element according to the invention, will also be able to function as a direction pointer or provide visual indication of the direction for opening of the screen element (door or window) due to its bent shape. With the two planar sectional elements of the door being mutually angled, it is also possible to obtain a light/shadow effect that will be able to break the visual experience of the wall portion wherein the screen element has been integrated.
Patent DE-60031042-D1 (DE)
Inventor: WARDLAW STEPHEN C
IPC: G01N15/05
Filed: 2000-06-21
Granted: 2006-11-16
Abstract: Centrifuged material layer volumes are measured and quantified during centrifugation of the material layers. The material layers are differentially highlighted by means of one or more supravital fluorescent dyes or stains which are admixed with the sample being analyzed. This kinetic quantification procedure is particularly useful in performing differential blood cell and platelet counts. The blood sample is centrifuged while being subjected to an intense filtered strobed light source at two different wavelengths. At least one photometric cell layer compaction measurement is made in conjunction with the light flashes so as to record a degree of cell layer compaction as the sample is being centrifuged. In certain cases, after several successive cell layer compaction readings are derived, a compaction curve is identified and the ultimate degree of cell layer compaction is calculated from the derived compaction curve prior to the achievement of the ultimate degree of cell layer compaction.  <IMAGE>
Patent DE-60044439-D1 (DE)
Inventor: DAHLLOEF HAKAN
IPC: D21C9/147
Filed: 2000-07-06
Granted: 2010-07-01
Abstract: The invention relates to a system and a process for the oxygen delignification of pulp consisting of lignocellulose-containing material whose mean concentration is 8-18% pulp consistency, in at least two stages.  The invention is characterized in that the oxygen delignification takes place in a first stage with a short dwell time of approx. 3-6 minutes, at a low temperature of approx. 85 DEG C and under a low pressure of approx. 0-4 bar, followed by a concluding stage with a longer dwell time of approx. 50-90 minutes, at a higher temperature of approx. 100 DEG C and under a higher pressure of approx. 8-10 bar.  This makes it possible, in an industrial process, to exploit the kinetics of the oxygen delignification in an optimal manner for the purpose of obtaining a selective oxygen delignification at low installation cost and at low operating cost. <IMAGE>
Patent DE-60101788-D1 (DE)
Inventor: ZALILA ZYED
IPC: B62D15/02
Filed: 2001-03-27
Granted: 2004-02-19
Abstract: A method and a device for slot parking of a mobile vehicle ( 1 ), the slot parking ( 15 ) includes positioning ( 19,22 ), locking ( 23,25 ), unlocking ( 26,27 ) and realigning ( 28,29 ) phases, the method using elements to evaluate available parking space relative to immediate surroundings. The method consists in: retrieving quantitative input values from sensors, which are transformed or not into gradual qualitative input values; determining on the basis of qualitative rules operating instructions which supply gradual qualitative output data and quantitative output data, which are transformed into quantitative output data to control the vehicle actuators. The invention is useful for parking any type of powered vehicles whereof the wheel can be locked on a common axle, and can be used on public roads, private parking lots or production sites of companies.
Patent DE-60102106-D1 (DE)
Inventor: FLIRI ANTON FRANZ JOSEF
IPC: A61P7/02
Filed: 2001-07-23
Granted: 2004-04-01
Abstract: The present invention provides diazabicyclooctane derivatives of formula (I): <CHEM>  and pharmaceutically acceptable salts thereof, wherein the group <CHEM>  represents <CHEM>     R<1> and R<2> are selected independently from H, (C1-C6)alkyl, (C1-C6)fluoroalkyl, halogen (e.g., F, Cl, Br, I), cyano, nitro, O-(C1-C6)alkyl, O-(C1-C6)fluoroalkyl, -NHC(O)R<4> and -OR<4>, where R<4> and R<5> are selected independently from H, (C1-C6)alkyl, and a 5- to 7-membered aryl or heteroaryl ring, or R<1> and R<2> together with the atoms to which they are attached, form a carbocyclic 5- or 6-membered ring or a heterocyclic 5- or 6-membered ring; and R<3> is selected from the group consisting of H, (C1-C6)alkyl, (CH2)m-aryl or (CH2)m-heteroaryl, wherein m is an integer from 1 to 4, each aryl or heteroaryl group optionally substituted with Cl, Br, CN, CF3, O-(C1-C6)alkyl, (C1-C6)alkyl, sulfonyl(C1-C6)alkyl, -CO(C1-C6)alkyl, -CONH2, -CONH(C1-C6)alkyl, -CON((C1-C6)alkyl)2, or CH(OH)(C1-C6)alkyl.   The invention also relates to pharmaceutical compositions of a compound of formula (I), and methods of use thereof in the treatment of diseases, conditions or disorders of the central nervous system. Further, the present invention is also directed to processes for the preparation of compounds of formula (I) and intermediates useful therefor.
Patent DE-60105035-D1 (DE)
Inventor: DELUCA F
IPC: A61Q19/00
Filed: 2001-06-11
Granted: 2004-09-23
Abstract: This invention discloses 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also has little, if any, calcemic activity and therefore may be used to treat immune disorders in humans as well as renal osteodystrophy.
Patent DE-60107205-D1 (DE)
Inventor: PIANTONI W
IPC: H01M50/167
Filed: 2001-01-30
Granted: 2004-12-23
Abstract: A forming die includes a base and at least two die segments. At least a first one of the die segments is moveably mounted to the base for shifting between closed and opened positions. The die segments together define a cavity having an opening when the first die segment is in the closed position. A punch is moveably mounted to the base for shifting between a retracted position and an extended position wherein the punch crimps a part positioned within the cavity. A powered actuator is connected to at least the first one of the die segments, and shifts the first die segment between the closed and opened positions such that a part positioned within the cavity can be removed after crimping by shifting of the first die segment to the open position. The forming die is particularly well-suited for crimping electrochemical cells.
Patent DE-60109071-D1 (DE)
Inventor: BELGERS JOHANNES ANTONIUS WOUT
IPC: E02D29/12
Filed: 2001-02-02
Granted: 2005-04-07
Abstract: A closing device 1 for the liquid-tight closing of an opening 37 in a floor 39 has a cover 3 and sealants 5. A sealing body 7, two closing elements 9 and 11 and movement elements 13 form the sealants 5. The closing elements 9 and 11 can be moved toward each other by a movement element 15 of the movement elements 13 to press the sealing body 7 together. Thus the sealing body 7 extends in a radial direction, so that the opening 37 is closed. Between a collar 45 at the end of the movement element 15 and the cover 3 and between the cover 3 and the floor 39 there are elastic rings 51 and 53. So the cover 3 is moveable with respect to the sealants. The sealing body 7 is not burdened if forces are exerted on the cover 3. In addition, the cover 3, when the movement element 15 is tightened, is pulled downward so that it comes to lie tightly against the floor 39. <IMAGE>
Patent DE-60122791-D1 (DE)
Inventor: SUH KWEE-HYUN
IPC: A61P31/04
Filed: 2001-03-14
Granted: 2006-10-12
Abstract: High purity clarithromycin of Form II crystals can be easily prepared in a high yield by a process comprising the steps of: protecting the 9-oxime hydroxy group of erythromycin A 9-oxime or a salt thereof with a tropyl group and the 2'- and 4''-hydroxy groups with trimethylsilyl groups; reacting 2',4''-O-bis(trimethylsilyl)erythromycin A 9-O-tropyloxime with a methylating agent; removing the protecting groups and the oxime group of 2',4''-O-bis(trimethylsilyl)-6-O-methylerythromycin A 9-O-tropyloxime to obtain crude clarithromycin; treating the crude clarithromycin with methanesulfonic acid in a mixture of a water-miscible organic solvent and water to obtain crystalline clarithromycin mesylate trihydrate; and neutralizing the crystalline clarithromycin mesylate trihydrate with aqueous ammonia in a mixture of a water-miscible organic solvent and water.
Patent DE-60126592-D1 (DE)
Inventor: HOUGHTON L
IPC: G01N33/574
Filed: 2001-04-02
Granted: 2007-03-29
Abstract: Compositions and methods for the therapy and diagnosis of cancer, such as breast cancer, are disclosed. Compositions may comprise one or more breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a breast tumor protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as breast cancer. Diagnostic methods based on detecting a breast tumor protein, or mRNA encoding such a protein, in a sample are also provided.
Patent DE-60127504-D1 (DE)
Inventor: TOULEMONDE CHARLES
IPC: E04B1/80
Filed: 2001-04-13
Granted: 2007-05-10
Abstract: An elementary module (21) having at least one beam, (11) made of a composite, and a longitudinal element, (22) made of an insulating material, right through which at least one channel (23) for housing the beam (11) passes. Also, a building structure provided with a thermal bridge break formed from such elementary modules (21).
Patent DE-60130533-D1 (DE)
Inventor: KIZAWA TOSHIHIRO
IPC: F24F6/10
Filed: 2001-05-18
Granted: 2007-10-31
Abstract: There are provided a humidifier, as well as an air conditioner using the same, capable of performing optimum humidification operation and improving comfort by resolving insufficient humidification. The humidifier includes a humidifying rotor (11), a moisture absorbing fan (13) provided on a moisture absorbing passage running through the humidifying rotor (11), a humidifying fan (15) provided on a humidifying passage running through the humidifying rotor (11), a motor (12) for the humidifying rotor for driving the humidifying rotor (11), and a heater (17) provided on the humidifying passage upstream from the humidifying rotor (11). At least one of the moisture absorbing fan (13), the humidifying fan (15), the motor (12) for the humidifying rotor and the heater (17) is controlled according to the outside air humidity. <IMAGE>
Patent DE-60133395-D1 (DE)
Inventor: KRONENTHAL DAVID
IPC: C07C271/18
Filed: 2001-07-20
Granted: 2008-05-08
Abstract: The present invention relates to a process for the preparation of alpha' chloroketones, such as 4-phenyl-3-t-butyloxy-carbonylamino)-2-keto-1-chlorobutane by reacting certain aryl amino acid esters, e.g. N-(2-t-butoxycarbonyl)-L-phenylalanine-4-nitrophenyl ester, with a sulfur ylide compound to form the corresponding keto ylide compound which is then treated with a source of chloride and an organic acid.
Patent DE-60138035-D1 (DE)
Inventor: PEHRSSON CLAES GOERAN
IPC: H04M1/724
Filed: 2001-11-09
Granted: 2009-04-30
Abstract: A portable communication device for conference calls, comprising at least first and second speech encoder paths with first and second inputs for connection to first and second recording devices, respectively, and at least one output connected to signal processor means for receiving and processing first and second electronic signals from said recording devices via said first and second speech encoder paths for transmission to a transmitter/receiver operatively connected to said signal processor means, wherein said apparatus is adpated to receive said first and second electronic signals simultaneously even if the signals are different, and said apparatus comprises a summator adapted to sum said first and second electronic signals into a sum signal for transmission to said transmitter/receiver.
Patent DE-60138290-D1 (DE)
Inventor: DENT PETER RICHARD
IPC: H03M13/23
Filed: 2001-12-20
Granted: 2009-05-20
Abstract: A wireless communications device (30) is disclosed, in which certain digital coding functions are realized according to a modified multiplier architecture. The device (30) includes an encode and modulate function (54) within which convolutional coding function (60) is provided. According to one alternative, convolutional coding function (60) is realized by way of a modified parallel multiplier (90), in which carries among adder units are ignored or not generated. The datastream x(k) is applied to the multiplier as the multiplicand, while successive sets of code generator polynomial coefficients are applied as a multiplier. The parallel multiplier (90) is modified in that carry-in and carry-out bits among the adder units are selectably blocked in a coding mode, but passed in a multiplier mode. A similar arrangement of a modified parallel multiplier circuit (90') may be used in generating a scrambling code that is applied prior to transmission. In either case, the modified multiplier architecture provides flexibility in the convolutional coding and in generation of the scrambling code, while not adversely impacting performance or chip area. <IMAGE>
Patent DE-60138998-D1 (DE)
Inventor: MCEWAN MALCOLM WILLIAM
IPC: B01J4/00
Filed: 2001-02-16
Granted: 2009-07-30
Abstract: A fluid inlet device for introducing a mixture of liquid and gas into a column provided with an inlet nozzle and with a horizontal gas/liquid contact tray arranged in the column below the inlet nozzle provided with a number of elongated downcomers between which bubbling areas are located, which inlet device consists of an inlet end that is in fluid communication with the inlet nozzle and a number of vertical vanes placed one behind the other, wherein each vane consists of two interconnected parts, an intercepting part and an outwardly directed deflecting part, wherein the intercepting part extends to the inlet end of the inlet device, and wherein an outlet channel defined by the deflecting parts of two adjacent vanes opens above a bubbling area of the contact tray.
Patent DE-60143537-D1 (DE)
Inventor: HATANO TAKESHI
IPC: D02G3/04
Filed: 2001-09-13
Granted: 2011-01-05
Abstract: The present invention relates to a method for producing a heat-resistant crimped yarn comprising twisting yarn of a heat-resistant high functional fiber, twist-setting the twisted yarn by heat treatment and untwisting the twist-set yarn, wherein the snarl value of the twist-set yarn is not more than 6.5, and provides a method for producing a heat-resistant crimped yarn which is practical in point of the productivity, the necessary equipment and the production costs. <IMAGE>
Patent DE-60203143-D1 (DE)
Inventor: GRUBER RUDOLF
IPC: F16C11/04
Filed: 2002-05-21
Granted: 2005-04-14
Abstract: An automotive hinge adapted to facilitate removable attachment of a closure panel to a body structure comprises a door component comprising upper and lower door component pivot arms adapted to be mounted to a vehicular closure panel, a body component comprising upper and lower body component pivot doors adapted to be mounted to a vehicular body structure, a common pivot axis around which the door component and body component are adapted to rotate in relation to each other, and a cylindrical protrusion adapted to be coaxially aligned with the pivot axis and structurally attached to and extended above the upper pivot arm of the body component, such that the door component is adapted to interleave over the body component, dimensionally locating the closure panel and the body structure by means of an external cylindrical bearing surface on the cylindrical protrusion, and is adapted to be held in assembly by means of a pivot pin which is adapted to extend through both said pivot arms of both said hinge components to create a fully structural, double hung pivot joint. <IMAGE>